Your search returned 16 studies. (Get alerts for new studies):
- Examining Heart Attacks in Young Women
Conditions: Myocardial Infarction
Location: Corvallis, Oregon
- Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
Conditions: Impetigo - Secondarily-infected Traumatic Lesions - Skin Diseases, Bacterial
Location: Corvallis, Oregon
- Community-based Intergenerational Oral Health Study
Conditions: Preventive Health Services
Location: Newport, Oregon
- Safety Study in Patients With Multiple Sclerosis Treated Fingoliomod or Other Approved Disease-modifying Therapies
Conditions: Multiple Sclerosis
Location: Corvallis, Oregon
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Corvallis, Oregon
- DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
Conditions: Cervical Dystonia
Location: Corvallis, Oregon
- ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry
Conditions: Opioid Dependence
Location: Corvalis, Oregon
- A Study in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Corvallis, Oregon
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Corvallis, Oregon
- A Biomarker Study of Secukinumab in Rheumatoid Arthritis Patients
Conditions: Rheumatoid Arthritis
Location: Corvallis, Oregon
- Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Conditions: Warfarin Initiation
Location: Corvallis, Oregon
- A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive
Conditions: Lymphoma, Non-Hodgkin - Lymphoma, B-cell - Lymphoma, B-cell, Diffuse
Location: Corvallis, Oregon
- A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive
Conditions: Lymphoma, Non-Hodgkin - Lymphoma, B-cell - Lymphoma, B-cell, Diffuse
Location: Newport, Oregon
- ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
Location: Corvallis, Oregon
- ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
Location: Lincoln City, Oregon
- ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
Location: Newport, Oregon
|